MarketWatch News on SYN
Wednesday’s biggest gaining & declining stocks 4:46 p.m. Nov. 30, 2011 - Kate Gibson
Adeona Pharmaceuticals shares down 9% 9:42 a.m. Dec. 29, 2010 - Nick Godt
Wednesday's biggest gaining and declining stocks 4:20 p.m. April 14, 2010 - MarketWatch
Adeona soars; Molecular Insight retreats. 3:13 p.m. April 14, 2010 - Val Brickates Kennedy
Adeona in spotlight; indices sluggish 8:56 a.m. April 14, 2010 - Val Brickates Kennedy
Advertisement
Other News on SYN
Synthetic Biologics' (SYN) CEO Jeff Riley on Q3 2014 Results - Earnings Call Transcript 2:14 p.m. Nov. 14, 2014 - Seeking Alpha
10-Q: SYNTHETIC BIOLOGICS, INC. 10:05 a.m. Nov. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Griffin Securities' Keith Markey On The Promise Of RNAi And Synthetic Biologics 7:54 a.m. Oct. 10, 2014 - Seeking Alpha
Forward Pharma on deck for IPO 7:33 a.m. Oct. 7, 2014 - Seeking Alpha
Synthetic Biologics' SYN-005 Gets Orphan Drug Designation - Analyst Blog 4:00 p.m. Sept. 16, 2014 - Zacks.com
Synthetic Biologics (SYN) Looks Strong: Stock Gains 13.9% - Tale of the Tape 7:44 a.m. Sept. 2, 2014 - Zacks.com
Synthetic Biologics (SYN) Jumps: Stock Adds 16% in Session - Tale of the Tape 7:51 a.m. Aug. 21, 2014 - Zacks.com
Synthetic Biologics' (SYN) CEO Jeff Riley on Q2 2014 Results - Earnings Call Transcript 1:30 p.m. Aug. 14, 2014 - Seeking Alpha
10-Q: SYNTHETIC BIOLOGICS, INC. 1:23 p.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Synthetic Biologics Inc. (SYN) Looks Strong as Stock Gains 34.3% - Tale of the Tape 7:44 a.m. July 30, 2014 - Zacks.com
Synthetic Bio up big on no news 1:04 p.m. July 29, 2014 - Seeking Alpha
Digesting The GMO Food Controversy And What It Means For Your Investment Portfolio 10:33 a.m. July 10, 2014 - Seeking Alpha
Why I'm Short Synthetic Biologics After Phase II Relapsing-Remitting MS Data 4:53 p.m. May 19, 2014 - Seeking Alpha
Why Synthetic Biologics (SYN) Stock Is Surging Today 11:50 a.m. May 15, 2014 - TheStreet.com
Synthetic Biologics' (SYN) CEO, Jeff Riley on Q1 2014 Results - Earnings Call Transcript 11:18 a.m. May 15, 2014 - Seeking Alpha
More on Synthetic Biologics Q1 results 9:48 a.m. May 15, 2014 - Seeking Alpha
Synovus sets 1:7 reverse stock split 7:34 a.m. April 25, 2014 - Seeking Alpha
AmpliPhi Biosciences: A Speculative Play In Biopharmaceuticals Too Compelling To Ignore 8:49 a.m. April 11, 2014 - Seeking Alpha
Are Tapeworms The Conceptual Key To The Next Multiple Sclerosis Blockbuster? 10:06 a.m. April 10, 2014 - Seeking Alpha
10-K: SYNTHETIC BIOLOGICS, INC. 3:52 p.m. March 31, 2014 - Edgar Online - (EDG = 10Q, 10K)
Loading more headlines...
Press Releases on SYN
Synthetic Biologics Reports Third Quarter 2014 Financial Results and Operational Highlights 6:56 a.m. Nov. 14, 2014 - PR Newswire - PRF
Synthetic Biologics to Report Third Quarter 2014 Financial Results 6:57 a.m. Nov. 6, 2014 - PR Newswire - PRF
Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 7:40 a.m. Oct. 30, 2014 - PR Newswire - PRF
Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 5:57 a.m. Oct. 22, 2014 - PR Newswire - PRF
Synthetic Biologics to Raise $20.7 Million in Registered Direct Offering 7:55 a.m. Oct. 10, 2014 - PR Newswire - PRF
Synthetic Biologics' Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Company's Investor Day 9:35 a.m. Sept. 16, 2014 - PR Newswire - PRF
Synthetic Biologics Receives Orphan Drug Designation for SYN-005 Treatment for Whooping Cough (Pertussis) 12:23 p.m. Sept. 12, 2014 - PR Newswire - PRF
Synthetic Biologics to Host Phase II Trimesta™ for Multiple Sclerosis Conference Call 5:58 a.m. Sept. 11, 2014 - PR Newswire - PRF
Synthetic Biologics to Webcast September 16, 2014 Irritable Bowel Syndrome (IBS) Investor Day 11:04 a.m. Sept. 10, 2014 - PR Newswire - PRF
Biotech Equities Technical Review -- Celldex Therapeutics, Synthetic Biologics, Geron, Catalyst Pharmaceutical Partners, and NPS Pharmaceuticals 8:15 a.m. Sept. 8, 2014 - PR Newswire - PRF
Synthetic Biologics Highlights SYN-005 Data Presented at the 54th ICAAC from Novel Whooping Cough (Pertussis) Program 5:58 a.m. Sept. 8, 2014 - PR Newswire - PRF
Synthetic Biologics Highlights New Data from C. difficile Program Presented at the 54th ICAAC 7:58 a.m. Sept. 7, 2014 - PR Newswire - PRF
Synthetic Biologics to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City 5:58 a.m. Sept. 3, 2014 - PR Newswire - PRF
Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 6:33 a.m. Sept. 2, 2014 - PR Newswire - PRF
Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 5:56 a.m. Aug. 28, 2014 - PR Newswire - PRF
Synthetic Biologics Announces Presentation of Poster for SYN-004 C. difficile Program at IDWeek 2014™ 5:58 a.m. Aug. 26, 2014 - PR Newswire - PRF
Synthetic Biologics to Host Irritable Bowel Syndrome (IBS) Investor Day 5:56 a.m. Aug. 13, 2014 - PR Newswire - PRF
Synthetic Biologics to Report Second Quarter 2014 Financial Results 5:56 a.m. Aug. 7, 2014 - PR Newswire - PRF
Synthetic Biologics on Track to Initiate Clinical Program for SYN-004 to Protect Against C. difficile 5:58 a.m. Aug. 5, 2014 - PR Newswire - PRF
Technical Data on Biotech Stocks -- Arrowhead Research, Celldex Therapeutics, Synthetic Biologics, StemCells, and Sarepta Therapeutics 7:50 a.m. Aug. 4, 2014 - PR Newswire - PRF
Loading more headlines...